Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
Anticancer Research · 2026
DOI: 10.21873/anticanres.18046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Samuli Salminen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland; samuli.salminen@hus.fi. Hauptthemen laut MEDLINE: Hemangiosarcoma, Breast Neoplasms, Neoplasms, Second Primary, Neoplasms, Radiation-Induced.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland; samuli.salminen@hus.fi.
- Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland.
- Finnish Medicines Agency FIMEA and University of Helsinki, Helsinki, Finland.
- Docrates Cancer Center, Helsinki, Finland.
- HUSLAB Pathology and University of Helsinki, Helsinki, Finland.
Zitieren
APA
Salminen, S., Tuomikoski, L., Tarkkanen, M., Wiklund, T., Tenhunen, M., Nevala, R., & Sampo, M. (2026). Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis. Anticancer Research. https://doi.org/10.21873/anticanres.18046
Vancouver
Salminen S, Tuomikoski L, Tarkkanen M, Wiklund T, Tenhunen M, Nevala R, et al. Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis. Anticancer Research. 2026. doi:10.21873/anticanres.18046
BibTeX
@article{Salminen2026,
author = {Salminen, Samuli and Tuomikoski, Laura and Tarkkanen, Maija and Wiklund, Tom and Tenhunen, Mikko and Nevala, Riikka and Sampo, Mika},
title = {Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18046}
}
EUVIMED